PHU

Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

UR SynKoMIC, Université Sorbonne Paris Nord
UFR SMBH
Porte 104, 1^er étage
74, rue marcel Cachin
93000 Bobigny

Je travaille sur l’optimisation du traitement des métastases cérébrales des cancers. En particulier, le passage des thérapies ciblées à travers la barrière hémato-encéphalique.

En collaboration avec d’autres équipes de recherche, nous travaillons sur un nouveau design d’anticorps thérapeutiques capables de traiter efficacement les métastases cérébrales.

Pour ce projet de recherche, nous avons mis au point une technique chirurgicale de pose de cathéters dans le système nerveux central sur des modèles animaux.
En parallèle, j'exerce mes activités cliniques au sein du service d'oncologie de l'hôpital Avicenne.

Mots clés : métastases cérébrales, cancer du sein HER2, anticorps thérapeutiques, pharmacocinétique.

Curriculum Vitae

ANGELI Eurydice

Date of birth: 14 may 1990, 2 children,

Orcid 0000-0001-5017-850X, WoS ResearcherID AAB-5899-2022

• FORMATION

2008-2014: Medical studies (Paris XIII) and internship in oncology (Paris)

2008: Master Degree (Paris XIII, and INSERM UMR1165, Pr Anne Janin)

2019: MD Thesis (Paris XIII University)

2020: Specialty Diploma in oncology (Paris XIII University)

2020-2022: Clinical fellowship at Avicenne Hospital in medical oncology unit, Sorbonne Paris Nord University

2022: PhD Thesis, University of Paris XIII, supervised by Prof. Guilhem Bousquet UMR_S1165.

• CURRENT FEATURES

2024- : Assistant Professor of Medical Oncology, Avicenne Hospital/Sorbonne Paris Nord University

2024- : Member of the SynKoMIC research unit, axis leader in biotherapy and brain metastases

Team Members: 25 members, of which 13 are women*, with 10 medical professors (Guilhem Bousquet, Anne Janin*, Géraldine Falgarone*, Cédric de Bazelaire, Eric de Kerviler, Nicolas Sellier, Pierre Mongiat-Artus, Laetitia Vercellino*, Michael Soussan, Frédéric Pamoukdjian), 1 MCF (Léa Rémy-Tourneur*), 1 PHU (Eurydice Angeli*), 1 PH Head of medical oncology unit (Diaddin Hamdan), 5 PhD students Thèse (Kelly Ngonfack*, Lola Blayac*, HOANG Manh Duc, Dina Allam*, Caleb Pop), 2 members of our International Associated Laboratory in Shanghai (Prof. ZHAO Weili*, Prof. WANG Li*), 4 members of the Translational Cancer Research Center in Hanoi (DAO Van Tu,  NGUYEN Thi Thuy, BUI Thi Oanh, NGUYEN Van Tai), 1 Associate Professor in Serbia University of Belgrade (J. Filipovic*).

• MOBILITY/POST-DOC

2022-2024: Clinical Fellowship at Institut Bergonié, Bordeaux, France, early phase clinical trial unit

• CONTINUING EDUCATION

2019: Diploma in Animal Experimentation, Maison Alfort

2021: Diploma in animal surgical Experimentation, Vetsalius

• AWARDS/DISTINCTIONS

2019: GPM award for medicine thesis

2025: Ruban Rose award (Prix Avenir, association Ruban Rose)

• STUDENT SUPERVISION

2022-2026: 1 higher national diploma (BTS bioanalyses et contrôles), 2 first year master’s degree, 2 master's degree, co supervision of 5 PhD Thesis (Justine Paris, defended in 2022; Caleb Pop and Dina Allam, first inscription in 2025; Lina Benakila and Nicolo Norri, first inscription in 2026)

• INVITED LECTURES

2024 : French Society of General Internal Medicine Congress

2026 : International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) “Measuring the Unmeasurable : Tucatinib Exposure in Plasma, CSF and Brain Tumor Tissue”

TEACHING COORDINATION

2024: Member of the education committee of an inter-university diploma (DIU) between two universities « Thérapies ciblées en oncologie et maladies chroniques inflammatoires».

Since 2025: Member of the OSCE stering comitee at Sorbonne Paris Nord University

• INSTITUTIONAL RESPONSIBILITIES

Since 2024 : Member of the local Animal Ethics Committee (Sorbonne Paris Nord University)

Since 2025 : Member of the Oncology Clinical Pharmacy Group (GPCO)

• CRITICAL REVIEW ACTIVITIES

Regular reviewer (8-10 article reviews/year): Communications Medicine, Frontiers, Experimental Hematology & Oncology, International Journal BMC Cancer, Biomolecules, Brain sciences, Current oncology, Cancers, Discover oncology, Nature, Diagnostics

2025: Guest Editor for Frontiers in oncology: «Novel Pharmaceutical Strategies for Targeting Brain Metastases »

2025: Guest Editor for Jove: «Experimental Approaches to Study Molecular Resistance in Cancer »

• FUNDING AND COLLABORATIONS

2025: Institutional call for proposal: PI: 13k€ (Sorbonne Paris Nord University)

2025: Ruban Rose Award, PI: 250k€

2025: Proof of concept funding, Fondation Carnot, co-PI: 30k€

2025: Institutional call for proposal: co-PI 20k€ (APHP-Hôpital Avicenne)